Hemostemix Announces Injunction Hearing Against Aspire Health Science, LLC
Calgary, Alberta--(Newsfile Corp. - June 3, 2020) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") is pleased to announce that it has retained DLA Piper, a global law firm, and filed for an injunction against Aspire Health Science, LLC, for the return of the Company's property. A hearing for the injunction is set for June 18, 2020 at 10:00 MDT before the Court of Queen's Bench, Alberta. Equally, the Company is pleased to announce DLA Piper filed an amended motion to...
2020-06-03 9:44 AM EDT
Hemostemix Announces Annual Special Meeting Results
Calgary, Alberta--(Newsfile Corp. - May 7, 2020) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") announces the Company completed its Annual Special Meeting of Shareholders on May 6, 2020. All motions put forward by management were approved by Shareholders, including the consolidation of the common shares on a one (1) new share for each 20 shares issued. The vote results are detailed in the attached table. Vote Details
2020-05-07 9:15 AM EDT
Hemostemix Announces Closing of Private Placement
Calgary, Alberta--(Newsfile Corp. - May 7, 2020) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") announces it has closed its previously announced non-brokered private placement of units ("Units") for gross proceeds of $1,291,500 (the "Offering"). The Offering consisted of the issuance of an aggregate of 129,150,000 Units at a price of $0.01 per Unit. Each Unit consists of one common share in the capital of the Company ("Common Share") and one common share purchase...
2020-05-07 9:10 AM EDT
Hemostemix Announces the Appointment of David Tsubouchi to its Board of Advisors
Calgary, Alberta--(Newsfile Corp. - April 30, 2020) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") is pleased to announce the appointment of David H. Tsubouchi, B.A., J.D., LL.D., D.S.Litt., C.Dir. to its Board of Advisors. David Tsubouchi is the first Japanese Canadian to be elected to any provincial legislature in Canada and to be appointed as a Cabinet Minister. He has served as the Minister of Consumer and Commercial Relations, Solicitor General, Chair of...
2020-04-30 9:15 AM EDT
Hemostemix Announces Private Placement and Debt Settlement Update
Calgary, Alberta--(Newsfile Corp. - April 29, 2020) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") is pleased to announce that, subject to TSX Venture Exchange ("TSXV") approval, its non-brokered private placement will be increased from $450,000 to $1,223,200 of units (the "Units") at $0.01 per Unit (the "Offering"), and the settlement ("Debt Settlement") of trade payables will amount up to $358,514 at $0.01 per common share. Each Unit of the Offering is comprised...
2020-04-29 9:15 AM EDT
Hemostemix Announces the Appointment of Timothy Chang to Board of Advisors
Calgary, Alberta--(Newsfile Corp. - April 21, 2020) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") is pleased to announce the appointment of Timothy C. Chang to its Board of Advisors. Mr. Chang is currently a Private Investor and an investment committee member of an Asian-based hedge fund with average total AUM of approximately US$1 billion. He has also been a consultant to Newport Healthcare Advisors and to SSG Capital Management. Mr. Chang is a renowned private...
2020-04-21 12:20 PM EDT
Hemostemix Announces the Appointments of Loran Swanberg and Christina Wu, CPA, CGA
Calgary, Alberta--(Newsfile Corp. - April 9, 2020) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") is pleased to announce the appointment of Mr. Loran Swanberg to its Board of Directors. Mr. Swanberg is a successful businessman who increased his ownership of the Company from 0.8% in 2019 to 7.8% in 2020. In combination with Mssrs. Lacey, Hershman and Smeenk, the board now owns 21% of the Company's shares. Mr. Swanberg has been part owner and a director of a private...
2020-04-09 9:15 AM EDT
Hemostemix Appoints the Honourable Sheila Copps, OC, PC, to Board of Advisors and Ratifies Thomas Smeenk as Chief Executive Officer
Calgary, Alberta--(Newsfile Corp. - April 7, 2020) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") is pleased to announce the appointment of the Honorable Sheila Copps, OC, PC, to its Board of Advisors. Sheila was the Deputy Prime Minister of Canada, Minister of Environment, Minister of Heritage and a senior member of the federal cabinet for 10 years. From her work on diversity and inclusion, to protection of the environment, to support for young Canadians and...
2020-04-07 9:15 AM EDT
Hemostemix Announces Closing of Second Tranche of Private Placement
Calgary, Alberta--(Newsfile Corp. - March 26, 2020) - Hemostemix Inc. ("Hemostemix" or the "Company") (TSXV: HEM) (OTC: HMTXF) announces it has closed the second tranche of its previously announced non-brokered private placement of units ("Units") for gross proceeds of up to $3,000,000 (the "Offering"). The second tranche of the Offering consisted of the issuance of an aggregate of 17,750,000 Units at a price of $0.01 per Unit for gross proceeds of $177,500. Each Unit consists of one common...
2020-03-26 8:00 PM EDT
Hemostemix Announces Peter Lacey as Chairman of the Board of Directors
Calgary, Alberta--(Newsfile Corp. - March 19, 2020) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") is pleased to announce the election of Mr. Peter Lacey, ICD.D as Chairman of its Board of Directors. Peter Lacey is currently the Chairman of Cervus Equipment Corporation (CERV.TO), a company he and his partners started in 1999 and built from five John Deere dealerships into a company that owns 63 dealerships selling six brands in three countries with revenues of $1.1...
2020-03-19 9:00 AM EDT
Hemostemix Announces Dr. York Hsiang Joins Its Scientific Advisory Board
Calgary, Alberta--(Newsfile Corp. - March 16, 2020) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") is pleased to announce the appointment of York N. Hsiang, MB. ChB, MHSc, FRCSC, Professor of Vascular Surgery at the University of British Columbia, and Consultant Surgeon at the Vancouver General Hospital, to its Scientific Advisory Board ("SAB"). Born in Taiwan, educated in the United States, New Zealand, and Canada, Dr. Hsiang has diverse interests in vascular...
2020-03-16 9:00 AM EDT
Hemostemix Announces Corporate Update
Calgary, Alberta--(Newsfile Corp. - March 10, 2020) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") is pleased to announce it has paid $2,330,633.84 to counsel for J.M. Wood Investments Ltd,("JM Wood") in full satisfaction of the Court of Queen's Bench of Alberta Order dated February 28, 2020. JM Wood's application for the appointment of a receiver is now dismissed. Pursuant to the Order, the Company paid into trust with counsel for JM Wood, on March 9, 2020, the...
2020-03-10 9:09 PM EDT
Hemostemix Announces Closing of First Tranche of Private Placement
Calgary, Alberta--(Newsfile Corp. - March 5, 2020) - Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) ("Hemostemix" or the "Company") announces it has closed the initial tranche of its previously announced non-brokered private placement of units ("Units") for gross proceeds of up to $3,000,000 (the "Offering"). The first tranche of the Offering consisted of the issuance of an aggregate of 254,620,442 Units at a price of $0.01 per Unit for gross proceeds of $2,546,204.42. Each Unit consists of one...
2020-03-05 4:05 PM EST
IIROC Trade Resumption - Hemostemix Inc.
Vancouver, British Columbia--(Newsfile Corp. - February 9, 2017) - Trading resumes in: Company: Hemostemix Inc.
2017-02-09 4:11 PM EST
IIROC Trade Halt - Hemostemix Inc.
Vancouver, British Columbia--(Newsfile Corp. - January 6, 2017) - The following issues have been halted by IIROC: Company:
2017-01-06 1:08 PM EST